The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global CAR-T Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CAR-T Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CAR-T Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CAR-T Therapy in Acute Lymphocytic Leukemia is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CAR-T Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech and Atara Biotherapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CAR-T Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Therapy.
Report Scope
The CAR-T Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CAR-T Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Novartis AG
- Kite Pharma
- Pfizer
- Juno Therapeutics
- Celgene Corporation
- CARsgen Therapeutics
- Sorrento Therapeutics
- Legend Biotech
- Atara Biotherapeutics
- Aurora Biopharma
- Autolus Therapeutics PLC
- Bluebird
- Carina Biotech
Segment by Type
- CD19
- CD22
- Other
Segment by Application
- Acute Lymphocytic Leukemia
- Diffuse Large B Cell Lymphoma
- Follicular Lymphoma
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CD19
1.2.3 CD22
1.2.4 Other
1.3 Market by Application
1.3.1 Global CAR-T Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Acute Lymphocytic Leukemia
1.3.3 Diffuse Large B Cell Lymphoma
1.3.4 Follicular Lymphoma
1.3.5 Chronic Lymphocytic Leukemia
1.3.6 Multiple Myeloma
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Therapy Market Perspective (2019-2030)
2.2 CAR-T Therapy Growth Trends by Region
2.2.1 Global CAR-T Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CAR-T Therapy Historic Market Size by Region (2019-2024)
2.2.3 CAR-T Therapy Forecasted Market Size by Region (2025-2030)
2.3 CAR-T Therapy Market Dynamics
2.3.1 CAR-T Therapy Industry Trends
2.3.2 CAR-T Therapy Market Drivers
2.3.3 CAR-T Therapy Market Challenges
2.3.4 CAR-T Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Therapy Players by Revenue
3.1.1 Global Top CAR-T Therapy Players by Revenue (2019-2024)
3.1.2 Global CAR-T Therapy Revenue Market Share by Players (2019-2024)
3.2 Global CAR-T Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR-T Therapy Revenue
3.4 Global CAR-T Therapy Market Concentration Ratio
3.4.1 Global CAR-T Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Therapy Revenue in 2023
3.5 CAR-T Therapy Key Players Head office and Area Served
3.6 Key Players CAR-T Therapy Product Solution and Service
3.7 Date of Enter into CAR-T Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Therapy Breakdown Data by Type
4.1 Global CAR-T Therapy Historic Market Size by Type (2019-2024)
4.2 Global CAR-T Therapy Forecasted Market Size by Type (2025-2030)
5 CAR-T Therapy Breakdown Data by Application
5.1 Global CAR-T Therapy Historic Market Size by Application (2019-2024)
5.2 Global CAR-T Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CAR-T Therapy Market Size (2019-2030)
6.2 North America CAR-T Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CAR-T Therapy Market Size by Country (2019-2024)
6.4 North America CAR-T Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Therapy Market Size (2019-2030)
7.2 Europe CAR-T Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CAR-T Therapy Market Size by Country (2019-2024)
7.4 Europe CAR-T Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Therapy Market Size (2019-2030)
8.2 Asia-Pacific CAR-T Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CAR-T Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific CAR-T Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR-T Therapy Market Size (2019-2030)
9.2 Latin America CAR-T Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CAR-T Therapy Market Size by Country (2019-2024)
9.4 Latin America CAR-T Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Therapy Market Size (2019-2030)
10.2 Middle East & Africa CAR-T Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CAR-T Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa CAR-T Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG CAR-T Therapy Introduction
11.1.4 Novartis AG Revenue in CAR-T Therapy Business (2019-2024)
11.1.5 Novartis AG Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Detail
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma CAR-T Therapy Introduction
11.2.4 Kite Pharma Revenue in CAR-T Therapy Business (2019-2024)
11.2.5 Kite Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer CAR-T Therapy Introduction
11.3.4 Pfizer Revenue in CAR-T Therapy Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Detail
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics CAR-T Therapy Introduction
11.4.4 Juno Therapeutics Revenue in CAR-T Therapy Business (2019-2024)
11.4.5 Juno Therapeutics Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Detail
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation CAR-T Therapy Introduction
11.5.4 Celgene Corporation Revenue in CAR-T Therapy Business (2019-2024)
11.5.5 Celgene Corporation Recent Development
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Detail
11.6.2 CARsgen Therapeutics Business Overview
11.6.3 CARsgen Therapeutics CAR-T Therapy Introduction
11.6.4 CARsgen Therapeutics Revenue in CAR-T Therapy Business (2019-2024)
11.6.5 CARsgen Therapeutics Recent Development
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Detail
11.7.2 Sorrento Therapeutics Business Overview
11.7.3 Sorrento Therapeutics CAR-T Therapy Introduction
11.7.4 Sorrento Therapeutics Revenue in CAR-T Therapy Business (2019-2024)
11.7.5 Sorrento Therapeutics Recent Development
11.8 Legend Biotech
11.8.1 Legend Biotech Company Detail
11.8.2 Legend Biotech Business Overview
11.8.3 Legend Biotech CAR-T Therapy Introduction
11.8.4 Legend Biotech Revenue in CAR-T Therapy Business (2019-2024)
11.8.5 Legend Biotech Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Detail
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics CAR-T Therapy Introduction
11.9.4 Atara Biotherapeutics Revenue in CAR-T Therapy Business (2019-2024)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Detail
11.10.2 Aurora Biopharma Business Overview
11.10.3 Aurora Biopharma CAR-T Therapy Introduction
11.10.4 Aurora Biopharma Revenue in CAR-T Therapy Business (2019-2024)
11.10.5 Aurora Biopharma Recent Development
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Detail
11.11.2 Autolus Therapeutics PLC Business Overview
11.11.3 Autolus Therapeutics PLC CAR-T Therapy Introduction
11.11.4 Autolus Therapeutics PLC Revenue in CAR-T Therapy Business (2019-2024)
11.11.5 Autolus Therapeutics PLC Recent Development
11.12 Bluebird
11.12.1 Bluebird Company Detail
11.12.2 Bluebird Business Overview
11.12.3 Bluebird CAR-T Therapy Introduction
11.12.4 Bluebird Revenue in CAR-T Therapy Business (2019-2024)
11.12.5 Bluebird Recent Development
11.13 Carina Biotech
11.13.1 Carina Biotech Company Detail
11.13.2 Carina Biotech Business Overview
11.13.3 Carina Biotech CAR-T Therapy Introduction
11.13.4 Carina Biotech Revenue in CAR-T Therapy Business (2019-2024)
11.13.5 Carina Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global CAR-T Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CD19
Table 3. Key Players of CD22
Table 4. Key Players of Other
Table 5. Global CAR-T Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global CAR-T Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global CAR-T Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global CAR-T Therapy Market Share by Region (2019-2024)
Table 9. Global CAR-T Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global CAR-T Therapy Market Share by Region (2025-2030)
Table 11. CAR-T Therapy Market Trends
Table 12. CAR-T Therapy Market Drivers
Table 13. CAR-T Therapy Market Challenges
Table 14. CAR-T Therapy Market Restraints
Table 15. Global CAR-T Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global CAR-T Therapy Market Share by Players (2019-2024)
Table 17. Global Top CAR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2023)
Table 18. Ranking of Global Top CAR-T Therapy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by CAR-T Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players CAR-T Therapy Product Solution and Service
Table 22. Date of Enter into CAR-T Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CAR-T Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global CAR-T Therapy Revenue Market Share by Type (2019-2024)
Table 26. Global CAR-T Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global CAR-T Therapy Revenue Market Share by Type (2025-2030)
Table 28. Global CAR-T Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global CAR-T Therapy Revenue Market Share by Application (2019-2024)
Table 30. Global CAR-T Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global CAR-T Therapy Revenue Market Share by Application (2025-2030)
Table 32. North America CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America CAR-T Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America CAR-T Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe CAR-T Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe CAR-T Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific CAR-T Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific CAR-T Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific CAR-T Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America CAR-T Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America CAR-T Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa CAR-T Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa CAR-T Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. Novartis AG Company Detail
Table 48. Novartis AG Business Overview
Table 49. Novartis AG CAR-T Therapy Product
Table 50. Novartis AG Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Kite Pharma Company Detail
Table 53. Kite Pharma Business Overview
Table 54. Kite Pharma CAR-T Therapy Product
Table 55. Kite Pharma Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 56. Kite Pharma Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer CAR-T Therapy Product
Table 60. Pfizer Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Juno Therapeutics Company Detail
Table 63. Juno Therapeutics Business Overview
Table 64. Juno Therapeutics CAR-T Therapy Product
Table 65. Juno Therapeutics Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 66. Juno Therapeutics Recent Development
Table 67. Celgene Corporation Company Detail
Table 68. Celgene Corporation Business Overview
Table 69. Celgene Corporation CAR-T Therapy Product
Table 70. Celgene Corporation Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 71. Celgene Corporation Recent Development
Table 72. CARsgen Therapeutics Company Detail
Table 73. CARsgen Therapeutics Business Overview
Table 74. CARsgen Therapeutics CAR-T Therapy Product
Table 75. CARsgen Therapeutics Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 76. CARsgen Therapeutics Recent Development
Table 77. Sorrento Therapeutics Company Detail
Table 78. Sorrento Therapeutics Business Overview
Table 79. Sorrento Therapeutics CAR-T Therapy Product
Table 80. Sorrento Therapeutics Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 81. Sorrento Therapeutics Recent Development
Table 82. Legend Biotech Company Detail
Table 83. Legend Biotech Business Overview
Table 84. Legend Biotech CAR-T Therapy Product
Table 85. Legend Biotech Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 86. Legend Biotech Recent Development
Table 87. Atara Biotherapeutics Company Detail
Table 88. Atara Biotherapeutics Business Overview
Table 89. Atara Biotherapeutics CAR-T Therapy Product
Table 90. Atara Biotherapeutics Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 91. Atara Biotherapeutics Recent Development
Table 92. Aurora Biopharma Company Detail
Table 93. Aurora Biopharma Business Overview
Table 94. Aurora Biopharma CAR-T Therapy Product
Table 95. Aurora Biopharma Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 96. Aurora Biopharma Recent Development
Table 97. Autolus Therapeutics PLC Company Detail
Table 98. Autolus Therapeutics PLC Business Overview
Table 99. Autolus Therapeutics PLC CAR-T Therapy Product
Table 100. Autolus Therapeutics PLC Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 101. Autolus Therapeutics PLC Recent Development
Table 102. Bluebird Company Detail
Table 103. Bluebird Business Overview
Table 104. Bluebird CAR-T Therapy Product
Table 105. Bluebird Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 106. Bluebird Recent Development
Table 107. Carina Biotech Company Detail
Table 108. Carina Biotech Business Overview
Table 109. Carina Biotech CAR-T Therapy Product
Table 110. Carina Biotech Revenue in CAR-T Therapy Business (2019-2024) & (US$ Million)
Table 111. Carina Biotech Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR-T Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CAR-T Therapy Market Share by Type: 2023 VS 2030
Figure 3. CD19 Features
Figure 4. CD22 Features
Figure 5. Other Features
Figure 6. Global CAR-T Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global CAR-T Therapy Market Share by Application: 2023 VS 2030
Figure 8. Acute Lymphocytic Leukemia Case Studies
Figure 9. Diffuse Large B Cell Lymphoma Case Studies
Figure 10. Follicular Lymphoma Case Studies
Figure 11. Chronic Lymphocytic Leukemia Case Studies
Figure 12. Multiple Myeloma Case Studies
Figure 13. Other Case Studies
Figure 14. CAR-T Therapy Report Years Considered
Figure 15. Global CAR-T Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global CAR-T Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global CAR-T Therapy Market Share by Region: 2023 VS 2030
Figure 18. Global CAR-T Therapy Market Share by Players in 2023
Figure 19. Global Top CAR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by CAR-T Therapy Revenue in 2023
Figure 21. North America CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America CAR-T Therapy Market Share by Country (2019-2030)
Figure 23. United States CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe CAR-T Therapy Market Share by Country (2019-2030)
Figure 27. Germany CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific CAR-T Therapy Market Share by Region (2019-2030)
Figure 35. China CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America CAR-T Therapy Market Share by Country (2019-2030)
Figure 43. Mexico CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa CAR-T Therapy Market Share by Country (2019-2030)
Figure 47. Turkey CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia CAR-T Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Novartis AG Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 50. Kite Pharma Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 52. Juno Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 53. Celgene Corporation Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 54. CARsgen Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 55. Sorrento Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 56. Legend Biotech Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 57. Atara Biotherapeutics Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 58. Aurora Biopharma Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 59. Autolus Therapeutics PLC Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 60. Bluebird Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 61. Carina Biotech Revenue Growth Rate in CAR-T Therapy Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
